Attached files
| file | filename |
|---|---|
| 10-Q/A - FORM 10-Q/A - SELLAS Life Sciences Group, Inc. | b88699e10vqza.htm |
| EX-31.1 - EX-31.1 - SELLAS Life Sciences Group, Inc. | b88699exv31w1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - SELLAS Life Sciences Group, Inc. | Financial_Report.xls |
Exhibit 32.1
CERTIFICATIONS PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Galena Biopharma, Inc. (the “Company”) on Form
10-Q/A for the period ended June 30, 2011 as filed with the Securities and Exchange Commission on
the date hereof (the “Report”), the undersigned officer of the Company certifies, pursuant to
18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to his
knowledge.
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material aspects, the
Company’s financial condition and result of operations.
October 28, 2011
| /s/ Mark J. Ahn | ||||
| Mark J. Ahn | ||||
| President, Chief Executive Officer and Chief Financial Officer | ||||